Literature DB >> 16270620

Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.

Bethan Freestone1, Gregory Y H Lip, Aun Yeong Chong, Sunil Nadar, Kaeng W Lee, Andrew D Blann.   

Abstract

Normal adults have very few circulating endothelial cells (CECs) in their blood, but increased levels have been shown in association with conditions associated with endothelial damage such as myocardial infarction and stroke. As atrial fibrillation (AF) is associated with a hypercoagulable state and abnormalities of plasma indices of endothelial damage/dysfunction, we hypothesised that CECs would also be raised in this condition, and would correlate with these plasma markers. We measured CECs (by immunofluoresence) as an indicator of frank endothelial damage, alongside 3 plasma indices of endothelial perturbation: von Willebrand factor (vWf), soluble E-selectin and soluble thrombomodulin (sTM) (all ELISA) in 28 patients with chronic 'stable' AF, 63 patients with AF plus an acute cardiovascular or cerebrovascular event as positive controls, and 20 healthy subjects in sinus rhythm as negative controls. Chronic 'stable' AF patients had significantly higher levels of plasma vWf (p<0.001 ), but comparable numbers of CECs (p=0.1638) in comparison to healthy controls. In patients with AF associated with an acute cardiovascular or cerebrovascular event, levels of CECs (p<0.0001) and sTM (p=0.004), but not vWf or sEsel, were significantly increased in comparison to chronic 'stable' AF patients. Patients with uncomplicated AF have abnormal systemic endothelial damage/dysfunction, as evident by increased plasma vWf levels, but normal numbers of CECs, compared to subjects in sinus rhythm. However, following clinical complications, such as stroke or significant haemodynamic compromise, further endothelial disturbance (as indicated by high levels of sTM and CECs) suggests additional endothelial damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16270620     DOI: 10.1160/TH05-02-0093

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  AF Detected on Implanted Cardiac Implantable Electronic Devices: Is There a Threshold for Thromboembolic Risk?

Authors:  Motaz Baibars; Khalil Kanjwal; Joseph E Marine
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-03

2.  Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage.

Authors:  Boris Leithäuser; Jai-Wun Park
Journal:  Korean Circ J       Date:  2009-11-30       Impact factor: 3.243

3.  Circulating endothelial progenitor cells and the risk of vascular events after ischemic stroke.

Authors:  Joan Martí-Fàbregas; Raquel Delgado-Mederos; Javier Crespo; Esther Peña; Rebeca Marín; Elena Jiménez-Xarrié; Ana Fernández-Arcos; Jesús Pérez-Pérez; Alejandro Martínez-Domeño; Pol Camps-Renom; Luís Prats-Sánchez; Francesca Casoni; Lina Badimon
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

4.  Integrated Analysis of the microRNA-mRNA Network Predicts Potential Regulators of Atrial Fibrillation in Humans.

Authors:  Rong Wang; Emre Bektik; Phraew Sakon; Xiaowei Wang; Shanying Huang; Xiangbin Meng; Mo Chen; Wenqiang Han; Jie Chen; Yanhong Wang; Jingquan Zhong
Journal:  Cells       Date:  2022-08-24       Impact factor: 7.666

Review 5.  Evidence-based percutaneous closure of the left atrial appendage in patients with atrial fibrillation.

Authors:  Silvio Leal; Raul Moreno; Manuel de Sousa Almeida; Jose Aniceto Silva; Jose L Lopez-Sendon
Journal:  Curr Cardiol Rev       Date:  2012-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.